Nikulski Financial Inc. Invests $594,000 in iShares Biotechnology ETF $IBB

Nikulski Financial Inc. purchased a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 3,522 shares of the financial services provider’s stock, valued at approximately $594,000.

A number of other large investors also recently bought and sold shares of the business. Darwin Wealth Management LLC purchased a new stake in iShares Biotechnology ETF in the second quarter worth $25,000. Ashton Thomas Securities LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter valued at $36,000. Parkside Financial Bank & Trust grew its holdings in shares of iShares Biotechnology ETF by 48.6% in the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after purchasing an additional 87 shares during the last quarter. Close Asset Management Ltd grew its holdings in shares of iShares Biotechnology ETF by 25.5% in the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after purchasing an additional 70 shares during the last quarter. Finally, Founders Financial Alliance LLC increased its stake in iShares Biotechnology ETF by 605.7% in the 3rd quarter. Founders Financial Alliance LLC now owns 374 shares of the financial services provider’s stock worth $54,000 after buying an additional 321 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 4.3%

IBB stock opened at $168.85 on Wednesday. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $179.64. The firm’s 50-day moving average is $170.97 and its 200 day moving average is $164.70.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were given a dividend of $0.1218 per share. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.